Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/245504
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Dataset related to article: Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics

AutorKoller, Dora; Almenara, Susana; Mejía, Gina; Saiz-Rodríguez, Miriam; Zubiaur, Pablo; Román, Manuel; Ochoa, Dolores; Navares-Gómez, Marcos; Santos-Molina, Elena; Pintos-Sánchez, Elena; Abad-Santos, Francisco
Palabras claveAripiprazole
Olanzapine
Metabolic changes
Fecha de publicación30-jun-2021
CitaciónKoller, Dora; Almenara, Susana; Mejía, Gina; Saiz-Rodríguez, Miriam; Zubiaur, Pablo; Román, Manuel; Ochoa, Dolores; Navares-Gómez, Marcos; Santos-Molina, Elena; Pintos-Sánchez, Elena; Abad-Santos, Francisco. (2021) "Dataset related to article: Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics [Dataset]", http://dx.doi.org/10.20350/digitalCSIC/13930
ResumenShort-term treatment with aripiprazole and olanzapine had a significant influence on the metabolic parameters. However, it seems that aripiprazole provokes less severe metabolic changes.
DescripciónThe data generated or analysed during this study are obtained included in the clinical trial registry name, URL and registration number: TREATMENT-HV; EUDRACT 2018-000744-26; https://eudract.ema. europa.eu/. File1 Adverse events after the treatment with antipsychotics
URIhttp://hdl.handle.net/10261/245504
DOI10.20350/digitalCSIC/13930
ReferenciasKoller, Dora; Almenara, Susana; Mejía, Gina; Saiz-Rodríguez, Miriam; Zubiaur, Pablo; Román, Manuel; Ochoa, Dolores; Navares-Gómez, Marcos; Santos-Molina, Elena; Pintos-Sánchez, Elena; Abad-Santos, Francisco. (2021). Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. Advances in Therapy 38: 1035-1054. https://doi.org/10.1007/s12325-020-01566-w. http://hdl.handle.net/10261/245492
Aparece en las colecciones: (IIBM) Conjuntos de datos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato
ADVERSE EFFECTS WITH ARI AND OLA.xlsx34,54 kBMicrosoft Excel XMLVisualizar/Abrir
Mostrar el registro completo

CORE Recommender
fair
fair eva

Page view(s)

136
checked on 18-may-2024

Download(s)

10
checked on 18-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


Este item está licenciado bajo una Licencia Creative Commons Creative Commons